Background
The World Health Organization estimates that cardiovascular disease (CVD) and depressive symptoms will become the most common causes of impaired health and function in the population, 1 which emphasizes the importance of developing and implementing easily accessible interventions targeting psychologic comorbidities for these patients. Management of depressive symptoms and insomnia 2,3 is a considerable challenge in the clinical care of patients with CVD. Drug treatment of depression and insomnia has shown unconvincing benefits and may lead to drug interactions, dependency, and fall injuries (e.g. during nightly awakenings). Another important aspect is that the effects of cardiac rehabilitation programmes and self-care interventions seem to be less favourable for patients with depression and CVD. 4 Thus, interventions addressing depressive symptoms and insomnia in patients with CVD are needed, but studies are few. Cognitive behavioural therapy (CBT) is a non-pharmacologic treatment option for depression and insomnia, but because of a shortage of psychologists, it is a challenge to provide faceto-face CBT to a large number of patients. 5 Internet-based CBT (I-CBT) led by nurses or other health care practitioners could be one solution in cardiovascular care, 6 leading to increased availability for patients, but there are only a few studies in the CVD setting. [7] [8] [9] 
Content and effects of I-CBT
A recent review reported that I-CBT needs to be based on several components aiming to decrease depressive symptoms among patients with CVD, 10 including psycho education, stimulus control, behavioural activation, problem solving, relaxation, and sleep restriction (i.e. if the patient suffers from insomnia). 11 Effectiveness can also depend on how disease specific the intervention is. A potential challenge is the limited knowledge of acceptability among stakeholders (e.g. patients, health care personnel and policy makers). Such knowledge is important to facilitate implementation in clinical care. An I-CBT programme encompassing all the components described above, 5 adapted to a CVD context, could be led by health care practitioners. 12 To enable use in clinical care, the effects for patients and the conditions for implementation need to be studied closely. However, these studies are missing in a cardiovascular setting.
How can we facilitate implementation of I-CBT in clinical practice?
Implementation of interventions in clinical practice can be challenging even though there is convincing evidence of efficacy and effectiveness. An I-CBT intervention for patients with CVD and psychologic distress is a complex intervention and therefore benefits from evaluation using different research designs and methods. 13 Successful implementation depends on a complex interplay between several
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determinants (i.e. barriers or facilitators). A combination of a randomized controlled trial (RCT) design (i.e. focusing on different quantitative patient-reported outcome measures) and qualitative methods (i.e. focusing on identifying facilitators and barriers as perceived by patients and practitioners) could therefore be used. Changing the management of depressive symptoms and insomnia requires research to identify the determinants to implementing and using a new practice and designing strategies to overcome barriers and build on facilitators. Data must be collected from multiple resources (i.e. patients, health care personnel and policy makers) to understand and explain the multiple interacting components that link the intervention to its outcomes.
How do we study the implementation of I-CBT in clinical practice?
An RCT is traditionally the scientific method of choice to evaluate a novel treatment to ascertain internal validity, that is, certainty of causality between an intervention and its outcomes. 14 As a result of the strict control of such trials, any positive or negative effect can be directly attributed to the intervention being studied. 14 In contrast, effectiveness trials are aimed at determining whether an intervention works under more realistic routine practice circumstances. A limitation of RCTs is the lack of in-depth understanding of 'how' or 'why' an intervention works because the focus of efficacy trials is on 'does it work?' Hence, effectiveness trials that show no significant results may be the result of a lack of proper implementation or weak acceptance or adherence by participants.
For this reason, additional methodological approaches 13 studying the mechanisms of the intervention as well as the characteristics of the patients and contexts in which the intervention takes place can provide answers to questions of what works, for whom, and in what circumstances. 13 Key determinants identified are: the characteristics of the intervention; characteristics of the implementers (i.e. typically health care providers) and content; characteristics of the target population (i.e. usually patients); and contextual conditions (i.e. typically understood as the levels above the individual). 15 Further, the effectiveness of the strategies used to facilitate the implementation (e.g. education for health care professionals to understand and use I-CBT) is also important. In short, numerous interdependent determinants have an impact on implementation success. A traditional RCT design in combination with methodological approaches focusing on the implementation process can therefore be suggested.
Conclusion
Although I-CBT appears to be a promising tool in clinical practice, both the effectiveness of the intervention and the implementation process need to be thoroughly evaluated in cardiovascular care. Knowledge regarding what works, for whom and in what circumstances is important information in addition to an RCT study. Hence, important questions concerning the mechanisms of the intervention should also be studied. The results of such a design will facilitate future decision making regarding implementation of I-CBT as an easily accessible tool in clinical practice.
